VIR
Vir Biotechnology, Inc. · Healthcare · Market cap $2.0B
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$8.3M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Latest filing
Oct 28, 2026
Sabatini Brent
Vir Biotechnology, Inc. (VIR) has 40 SEC Form 4 filings (57 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Oct 28, 2026.
Inside the rolling window, 8 insiders at Vir Biotechnology, Inc. reported no open-market purchases and 33 open-market sales totaling $8.3M. The most active filer is Director SATO VICKI L with 8 filings. Insiders have net sold $255K over the trailing 6 months. The most recent open-market filing is a sale of 379 shares by SVP, Chief Accounting Officer Sabatini Brent, dated Jun 1, 2026, worth $4K.
- Industry:Biotechnology
- CEO:Marianne De Backer
- Employees:367
- HQ:San Francisco, CA, US
- IPO:2019-10-11
| Source | |||||||
|---|---|---|---|---|---|---|---|
| SVP, Chief Accounting Officer | Sale | 379 | $4K | Jun 2 | +34.4% | SEC ↗ | |
Napolitano JanetFirst filing | Director | Sale | 3,200 | $30K | Jun 2 | +34.4% | SEC ↗ |
| Director | Sale | 22,000 | $221K | May 4 | +15.4% | SEC ↗ | |
| President and CEO | Sale | 72,559 | $664K | Apr 7 | +28.1% | SEC ↗ | |
| Director | Sale | 22,000 | $200K | Apr 2 | +29.7% | SEC ↗ | |
| SVP, Chief Accounting Officer | Sale | 7,711 | $70K | Mar 24 | +37.1% | SEC ↗ | |
| Director | Sale | 22,000 | $209K | Mar 3 | +31.9% | SEC ↗ | |
| Director | Sale | 42,377 | $413K | Feb 26 | +26.1% | SEC ↗ | |
| EVP, General Counsel, Corp Sec | Sale | 3,117 | $30K | Feb 26 | — | SEC ↗ | |
| EVP, General Counsel, Corp Sec | Sale | 13,700 | $135K | Feb 26 | — | SEC ↗ | |
| EVP and Chief Medical Officer | Sale | 1,616 | $15K | Feb 26 | — | SEC ↗ | |
| EVP and Chief Medical Officer | Sale | 1,889 | $19K | Feb 26 | — | SEC ↗ | |
| SVP, Chief Accounting Officer | Sale | 1,430 | $14K | Feb 26 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 14,762 | $141K | Feb 26 | — | SEC ↗ | |
| EVP & Chief Financial Officer | Sale | 1,634 | $16K | Feb 26 | — | SEC ↗ | |
Eisner MarkFirst filing | EVP and Chief Medical Officer | Sale | 2,089 | $16K | Feb 24 | — | SEC ↗ |
de Verneuil VaninaFirst in 4 months | EVP, General Counsel, Corp Sec | Sale | 4,445 | $33K | Feb 24 | — | SEC ↗ |
De Backer MarianneFirst filing | Chief Executive Officer | Sale | 19,039 | $142K | Feb 24 | — | SEC ↗ |
| SVP, Chief Accounting Officer | Sale | 1,829 | $14K | Feb 24 | — | SEC ↗ | |
O'Byrne JasonFirst in 3 months | EVP & Chief Financial Officer | Sale | 2,089 | $16K | Feb 24 | — | SEC ↗ |
Sabatini BrentFirst filing | SVP, Chief Accounting Officer | Sale | 1,530 | $12K | Feb 18 | — | SEC ↗ |
| Director | Sale | 22,000 | $170K | Feb 3 | — | SEC ↗ | |
| Director | Sale | 22,000 | $130K | Jan 5 | — | SEC ↗ | |
| 10% Owner | Sale | 191,854 | $1.1M | Dec 3 | — | SEC ↗ | |
| Director | Sale | 22,000 | $132K | Dec 2 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does VIR have?
Vir Biotechnology, Inc. (VIR) has 40 SEC Form 4 filings (57 transaction rows) in the rolling 365-day window, disclosed by 8 distinct insiders. Most recent filing: Oct 28, 2026.
When was the most recent SEC Form 4 filing for VIR?
The most recent Form 4 filing for VIR on Tracefour is dated Oct 28, 2026.
Who is the most active insider at VIR?
The most active SEC Form 4 filer at VIR in the rolling window is Director SATO VICKI L, with 8 filings.
What is the net insider flow at VIR over the last 6 months?
Over the trailing 180 days, insiders at VIR have net sold $255K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at VIR in the current window?
Inside the rolling window, insiders at VIR bought $0 and sold $8.3M based on SEC Form 4 filings.
Can I get alerts for VIR insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Vir Biotechnology, Inc. (VIR). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Vir Biotechnology, Inc. is in the Healthcare sector.